Multinational Point Prevalence Study on the Management of Diabesity in Hospitals

NCT06680674 | Active Not Recruiting DMC

• 1 other identifier: EK 1828/2024
• Study Type: observational
• Target: 400
• Locations: 8 countries
• Sites: 8

Brief Summary

Diabetes related to obesity ("diabesity") is becoming increasingly prevalent. Hospitalizations among people with diabetes are frequent and glycaemic control is often suboptimal during these stays. However, the pharmacological treatment of diabesity has made significant progress in recent years. The objective of this study is to assess the management of diabesity in the international hospital setting. Aims include:

1. 1.to determine the prevalence of causes and duration of hospitalization
2. 2.to investigate the treatments used
3. 3.to determine individual metabolic control achived This is a cross-sectional multi-centre study in which researchers will conduct a one-day point prevalence assessment in internal medicine wards.

Conditions

Diabetes Mellitus; Obesity

Outcome Measures

Primary Outcomes (1)

• Number of point-of-care glucose values

  Mean number of point-of-care glucose measurements during hospitalization

  3 days

Secondary Outcomes (1)

• Severe hypoglycaemia

  From day of admission to the day of data collection, i.e., November 14, 2024

Other Outcomes (2)

• Diabetes treatment during hospitalization

  From day of admission to the day of data collection, i.e., November 14, 2024

• Insulin regimen during hospitalization

  From day of admission to the day of data collection, i.e., November 14, 2024

Interventions

Routine care for people with diabetes, with or without obesity, in the hospital setting OTHER

Routine care for people with diabetes, with or without obesity, in the hospital setting, including routine pharmacological treatment for diabetes and obesity.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adults (age ≥ 18 years) with diabetes who are admitted to an internal medicine ward of a participating medical centre at the time of the study

You may qualify if:

• Hospitalized at the time of the survey for any cause
• Diabetes diagnosis (Known / documented in medical history or newly diagnosed using ADA diagnostic criteria)
• Age ≥ 18 years
• Written informed consent

You may not qualify if:

• Patients in wards and units other than internal medicine wards (such as outpatient areas, emergency departments, skilled nursing and intensive care units, etc.)
• Paediatric patients (Age \< 18 years)
• Patients without a diabetes diagnosis

Sponsors & Collaborators

• Medical University of Vienna: lead
• Hospital de Cascais Dr. José de Almeida (Portugal): collaborator
• Centre Hospitalier Universitaire Sétif, Service Médecine Interne (Algeria): collaborator
• Rabin Medical Center: collaborator
• Hospital Regional de Malaga: collaborator
• Charles University, Czech Republic: collaborator
• University Hospital Bratislava: collaborator
• Complejo Hospitalario de Especialidades Juan Ramón Jimenez: collaborator
• Medical University Innsbruck: collaborator
• Aristotle University Of Thessaloniki: collaborator
• Rostov State Medical University: collaborator
• Hospital Marina Baixa: collaborator
• Riga East Clinical University Hospital: collaborator
• University Hospital, Aachen: collaborator
• San Raffaele University Hospital, Italy: collaborator
• Kanuni Sultan Suleyman Training and Research Hospital: collaborator

Study Sites (8)

Medical University of Vienna

Vienna, 1090, Austria

Location

General University Hospital in Prague

Prague, Czechia

Location

University Hospital RWTH Aachen

Aachen, Germany

Location

Hippokration General Hospital, Aristotle University of Thessaloniki

Thessaloniki, Greece

Location

Rabin Medical Center, Hasharon Hospital

Petah Tikva, Israel

Location

Riga East Clinical University Hospital

Riga, Latvia

Location

Rostov State Medical University

Rostov-on-Don, Russia

Location

Kanuni Sultan Suleyman Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus; Obesity

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Overweight; Overnutrition; Nutrition Disorders; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Alexandra Kautzky-Willer, Prof

  Medical University of Vienna

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research Assistant (PhD)

Study Record Dates

• First Submitted: November 6, 2024
• First Posted: November 8, 2024
• Study Start: November 13, 2024
• Primary Completion: March 18, 2025
• Study Completion: May 31, 2025
• Last Updated: May 8, 2025

Record last verified: 2025-05

Data Sharing

• IPD Sharing: Will not share

Locations

GR (1); IL (1); LA (1); TU (1); RU (1); CZ (1); AU (1); DE (1)